Charles Schwab Investment Management Inc Atossa Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 369,988 shares of ATOS stock, worth $562,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
369,988
Previous 45,962
704.99%
Holding current value
$562,381
Previous $82,000
436.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ATOS
# of Institutions
81Shares Held
25.8MCall Options Held
404KPut Options Held
83.6K-
Black Rock Inc. New York, NY9.2MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.49MShares$9.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.77MShares$4.21 Million0.0% of portfolio
-
State Street Corp Boston, MA1.66MShares$2.53 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.55MShares$2.36 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $192M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...